Belvedere Trading LLC Buys New Shares in VanEck Pharmaceutical ETF $PPH

Belvedere Trading LLC purchased a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 33,767 shares of the company’s stock, valued at approximately $3,484,000. VanEck Pharmaceutical ETF accounts for approximately 0.0% of Belvedere Trading LLC’s investment portfolio, making the stock its 24th largest position. Belvedere Trading LLC owned 0.31% of VanEck Pharmaceutical ETF as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of PPH. AlphaCore Capital LLC bought a new position in VanEck Pharmaceutical ETF during the fourth quarter worth about $31,000. IFP Advisors Inc grew its holdings in VanEck Pharmaceutical ETF by 53.7% during the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after purchasing an additional 153 shares during the period. Advisory Services Network LLC bought a new position in VanEck Pharmaceutical ETF during the third quarter worth about $41,000. CWM LLC grew its holdings in VanEck Pharmaceutical ETF by 36.3% during the fourth quarter. CWM LLC now owns 511 shares of the company’s stock worth $53,000 after purchasing an additional 136 shares during the period. Finally, Farther Finance Advisors LLC grew its holdings in VanEck Pharmaceutical ETF by 64.7% during the fourth quarter. Farther Finance Advisors LLC now owns 718 shares of the company’s stock worth $74,000 after purchasing an additional 282 shares during the period.

VanEck Pharmaceutical ETF Stock Performance

VanEck Pharmaceutical ETF stock opened at $104.74 on Friday. VanEck Pharmaceutical ETF has a 52 week low of $81.74 and a 52 week high of $112.58. The stock has a market capitalization of $993.98 million, a P/E ratio of 20.21 and a beta of 0.46. The stock has a 50-day simple moving average of $102.50 and a 200 day simple moving average of $103.94.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 7th. Investors of record on Wednesday, April 1st were issued a dividend of $0.8441 per share. The ex-dividend date was Wednesday, April 1st. This is an increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. This represents a $3.38 dividend on an annualized basis and a yield of 3.2%.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.